MG
Mountain Group Capital
Micro VCActiveMountain Group Partners is an investor dedicated to investing in and actively guiding transformation businesses in the Life Science.
51
Investments
10
Exits
$544M
AUM
19.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Mountain Group Capital.
Investment Thesis & Strategy
Mountain Group Capital invests in fintech companies across various stages, seeking to guide transformative businesses in the life science sector.
Investment Activity
Deals per year over the last 13 years
1
20072
20080
20091
20101
20112
20121
20132
20140
20150
20160
20171
20181
2019Portfolio Companies
Selected investments from their portfolio of 51 companies
S
Sollis Therapeutics
Biotech · Series A, 2019
X
Xalud Therapeutics
Biotech · Series A, 2018
C
Cerecor
Biotech · Series A, 2014
I
Inscripta
Biotech · Series A, 2014
A
Aspire Health
Healthcare · Series A, 2013
V
Vapotherm
Healthcare · Series A, 2012
R
Rani Therapeutics
Biotech · Series A, 2012
V
Vaxart
Biotech · Series A, 2011
V
Vascular Therapies
Biotech · Series A, 2010
O
Oncothyreon
Biotech · Series A, 2008
A
Aethlon Medical
Biotech · Series A, 2008
B
BioDelivery Sciences International
Biotech · Series A, 2007
Frequently Asked Questions
Mountain Group Capital focuses on Seed, Series A stage investments.
Related Investors
TriStar Health Partners
Nashville, United States · 45 deals
Frist Cressey Ventures
Nashville, United States · 14 deals
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals
Kima Ventures
Paris, France · 565 deals
Alumni Ventures Group
Manchester, United States · 442 deals